WEDNESDAY, Aug. 4 (HealthDay News) -- Children taking tumor necrosis factor a (TNFa) blockers may be at increased risk for developing malignancies, but confounding factors make it difficult to establish a causal relationship, according to research published in the August issue of Arthritis & Rheumatism.
